Navigation Links
Scientists create stable, self-renewing neural stem cells
Date:4/25/2011

Assays of these neural precursor cells found no evidence of tumor formation when introduced into laboratory mice.

By adding other chemicals, the scientists are able to then direct the precursor cells to differentiate into different types of mature neurons, "which means you can explore potential clinical applications for a wide range of neurodegenerative diseases," said Zhang. "You can generate neurons for specific conditions like amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), Parkinson's disease or, in the case of my particular research area, eye-specific neurons that are lost in macular degeneration, retinitis pigmentosa or glaucoma."

The new process promises to have broad applications in stem cell research. The same method can be used to push induce pluripotent stem cells (stem cells artificially derived from adult, differentiated mature cells) to become neural stem cells, Zhang said. "And in principle, by altering the combination of small molecules, you may be able to create other types of stem cells capable of becoming heart, pancreas, or muscle cells, to name a few."

The next step, according to Zhang, is to use these stem cells to treat different types of neurodegenerative diseases, such as macular degeneration or glaucoma in animal models.


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Musicians and scientists to research mind and music at Rice University conference
2. Scientists Discover How Peppermint Soothes Gastric Pain
3. Scientists develop compound that effectively halts progression of multiple sclerosis
4. Scientists Spot Key Gene Mutations in Melanoma
5. Illusion can halve the pain of osteoarthritis, scientists say
6. Berkeley Lab scientists find that normal breast cells help kill cancer cells
7. Artery Plaque Forms in Short Time Span, Scientists Say
8. Scientists Complete Detailed Map of Human Brain
9. Feinstein scientists identify abnormal disease pathway in dystonia
10. Scientists find potential benefit of hypericin for recurrent brain tumors
11. Scientists Use Computer to Read Human Thoughts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists create stable, self-renewing neural stem cells
(Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... Avid collector ... and the Doors Shrine Auditorium concert posters. This hand colored artwork is one of ... 23 in Los Angles. Hawley states, "When the doors played the Shrine, the ...
(Date:8/30/2015)... (PRWEB) , ... August 31, 2015 , ... ... Magazine: The Fun Cooking Magazine for Kids , recently elected two new officers ... These appointments will further ChopChop’s mission of inspiring and teaching kids to cook ...
(Date:8/30/2015)... , ... August 30, 2015 , ... Scientists in France ... also a range of digestive cancers. Surviving Mesothelioma has just posted an article on ... the University of Caen measured the cancer incidence among 2,024 French asbestos plant workers ...
(Date:8/30/2015)... Raton, Fl (PRWEB) , ... August 30, 2015 ... ... that Kathleen Kall has been promoted from Administrative assistant to Executive Assistant to ... you’ll interact with a proven professional, focused on your goals. Kathleen graduated ...
(Date:8/29/2015)... , ... August 29, 2015 , ... On Saturday, September ... Mesothelioma Applied Research Foundation (Meso Foundation) will present an educational program titled “Asbestos ... PM and lasts through 9:30 PM (doors open at 6:45pm) at Calvary United Methodist ...
Breaking Medicine News(10 mins):Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 2Health News:ChopChop Kids Appoints New Chair and Vice-Chair to Board of Directors 3Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2
... following Webcast:, What: HCA Healthcare Webcast, ... Where: http://www.videonewswire.com/event.asp?id=55052 , How: ... address above., ... +1-615 344 2688, , ...
... Power, a business of Emerson and the global leader in ... series wall mount switching adapters, designed specifically for medical and ... ... Carlsbad, CA (PRWEB) January 27, 2009 -- Emerson Network ...
... MENTOR, Ohio, Jan. 27 STERIS Corporation (NYSE:, ... 2009 third quarter ended,December 31, 2008. Fiscal 2009 ... $314.0 million in the third quarter of fiscal 2008,driven ... Fiscal 2009 third,quarter net income was $28.6 million, or ...
... Tenn., Jan. 27 LTC Consultants announced today,that its ... on,May 20-21, 2009 in Nashville, TN. , ... event of 2009 because it is,100% sales training from ... to Bill Pomakoy, LTC Consultants, VP of Marketing. ...
... WALTHAM, Mass., Jan. 27 Interleukin Genetics, Inc. (NYSE Alternext US: ... to the NYSE Alternext US LLC (the "Exchange") that outlines ... listing requirements. The Company expects the Exchange to formally ... plan is accepted, the Company may be able to continue ...
... Texas at San Antonio (UTSA) has received another boost ... been awarded a $199,884, 24-month grant by the U.S. ... is one of the first grants we have received ... efficiency," said Efstathios Michaelides, mechanical engineering professor, department chair ...
Cached Medicine News:Health News:Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications 2Health News:Emerson Network Power Introduces High Density AC-DC Adapters for Medical Applications 3Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 10Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 11Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 12Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 13Health News:STERIS Corporation Announces Fiscal 2009 Third Quarter Results 14Health News:Phyllis Shelton's LTCI Sales Skills Seminar a Must-Attend Event for Insurance Professionals 2Health News:Interleukin Genetics' Submits Plan to Regain Compliance with Continued Listing Standards 2Health News:UTSA receives federal funding for fossil fuel research 2
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015  Mylan ... its shareholders have approved Mylan,s proposed acquisition of ... and the related issuance of Mylan ordinary shares ... of shareholders held today. The transaction received the ... general meeting. In addition, the transaction received support ...
(Date:8/28/2015)... Massachusetts y LONDRES, 28 de agosto ... AEX: PHIA) anunció hoy su participación en el  ... exhibirá sus soluciones cardiológicas más recientes y novedosas, ... Cardiovascular, que conectan a las personas y la ... de ayudar a diagnosticar, guiar los tratamientos y ...
(Date:8/27/2015)... Aug. 27, 2015  The Academy of Managed ... Drug Administration,s (FDA,s) draft guidance and proposed rule ... biosimilars, to bear a nonproprietary name with an ... seeking a decision from the FDA on the ... care stakeholders urging the agency to use the ...
Breaking Medicine Technology:Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... Provides Tolerable and Effective Symptom Control, ... SHP, Nasdaq:,SHPGY, TSX: SHQ), the global specialty ... study of DAYTRANA(TM) (methylphenidate,transdermal system), the Attention ... provided significant ADHD tolerability,and symptom control improvement ...
... Anti-Tumor Activity of NKTR-102 Associated With Increased ... Tumor Tissue to the Active Metabolite of ... Nektar Therapeutics,(Nasdaq: NKTR ) presented positive ... NKTR-102 (PEG-irinotecan) at the AACR-NCI-EORTC,International Conference in ...
Cached Medicine Technology:Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 2Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 3Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 4Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system) 5NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 2NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 3NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 4NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models 5
1000 L, Bulk, blue Recommended for 500 and 1000 L pipettes....
... to order tips. Each box contains 1000 tips ... contains 200 tips (4 bags of 50 tips). ... 200 tips per pack. Bulk Packs are sealed ... opened for quick access to Gilsons Diamond Tips. ...
This 100 µL is the equivalent to the "Universal Blue" tips and fits virtually every manufacturer's 1000 µL Pipettor....
300 L, Bulk Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette...
Medicine Products: